# STOP HCC-GAAD-APAC-Thailand

> **NCT07319299** · NA · ENROLLING_BY_INVITATION · sponsor: **Mahidol University** · enrollment: 2100 (estimated)

## Conditions studied

- Hepatecellular Carcinoma
- Cirrhosis
- HBV Infection

## Interventions

- **DIAGNOSTIC_TEST:** GAAD score

## Key facts

- **NCT ID:** NCT07319299
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-02-02
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 2100 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07319299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07319299, "STOP HCC-GAAD-APAC-Thailand". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07319299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*